1. Home
  2. TH vs LBRX Comparison

TH vs LBRX Comparison

Compare TH & LBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Target Hospitality Corp.

TH

Target Hospitality Corp.

HOLD

Current Price

$6.97

Market Cap

669.5M

ML Signal

HOLD

LBRX

LB Pharmaceuticals Inc

N/A

Current Price

$22.46

Market Cap

563.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TH
LBRX
Founded
1978
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
669.5M
563.2M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
TH
LBRX
Price
$6.97
$22.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$13.00
$49.00
AVG Volume (30 Days)
311.7K
239.5K
Earning Date
11-06-2025
02-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$314,546,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.00
$13.36
52 Week High
$10.28
$24.46

Technical Indicators

Market Signals
Indicator
TH
LBRX
Relative Strength Index (RSI) 26.97 56.45
Support Level $7.28 $21.82
Resistance Level $7.76 $24.46
Average True Range (ATR) 0.25 1.90
MACD -0.12 0.17
Stochastic Oscillator 0.00 67.52

Price Performance

Historical Comparison
TH
LBRX

About TH Target Hospitality Corp.

Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. Its operating segment includes HFS-South and HFS-Midwest; Government; TCPL Keystone and others. It generates a majority of its revenue from the Government segment which consists of specialty rental and vertically integrated hospitality services revenue from customers with Government contracts located in Texas.

About LBRX LB Pharmaceuticals Inc

LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.

Share on Social Networks: